通过皮肤修复三管吐
Antonio Mangieri1,2, Antonio Colombo1,2
1Cardio Center, Humanitas Clinical and Research Center-IRCCS, Rozzano, Milan.
概括
三管吐 (TR) 是一种常见的疾病,与较高的死亡率有关. 过导管技术为需要修复三管的高风险患者提供了不那么侵入性的选择.
科学领域:
- 心脏病学 心脏病学
- 干预心脏病学 干预心脏病学
- 心脏外科手术 心脏外科手术
背景情况:
- 在患有左侧膜心脏病或心房动的患者中,三回 (TR) 很普遍.
- TR显著增加死亡率,发病率和住院风险.
- 传统的三手术修复带有高的手术风险和术后并发症.
研究的目的:
- 为了提供一个概述的当前状态的跨导管修复性治疗的TR.
- 为了突出新兴的三门修复器件.
主要方法:
- 对皮肤穿三管修复的当前文献的综述.
- 讨论临床开发中的新型设备和技术.
主要成果:
- 穿皮干预正在成为选择高风险患者的可行替代方案.
- 目前正在研究几种用于跨导管三管修复的新设备.
结论:
- 过导管修复治疗是管理高风险人群中TR的有希望的方法.
- 进一步的研究和设备开发对于优化三回治疗结果至关重要.
相关概念视频
Mitral Regurgitation III: Medical Management
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
Mitral Stenosis III: Medical Management
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Aortic Regurgitation III: Medical Management
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Pericarditis III: Medical Management
The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...


